25.86
前日終値:
$24.82
開ける:
$24.96
24時間の取引高:
241.60K
Relative Volume:
0.79
時価総額:
$1.51B
収益:
-
当期純損益:
-
株価収益率:
-
EPS:
-
ネットキャッシュフロー:
-
1週間 パフォーマンス:
+12.43%
1か月 パフォーマンス:
-4.68%
6か月 パフォーマンス:
+56.25%
1年 パフォーマンス:
+0.00%
Kestra Medical Technologies Ltd Stock (KMTS) Company Profile
名前
Kestra Medical Technologies Ltd
セクター
電話
(425) 279-8002
住所
3933 LAKE WASHINGTON BLVD NE, KIRKLAND
KMTS を他の銘柄と比較する
| 株式 | 価格 | 時価総額 | 収益 | 当期純利益 | 現金流量 | EPS |
|---|---|---|---|---|---|---|
|
KMTS
Kestra Medical Technologies Ltd
|
25.86 | 1.45B | 0 | 0 | 0 | 0.00 |
|
ISRG
Intuitive Surgical Inc
|
525.04 | 187.46B | 10.06B | 2.88B | 2.27B | 7.8807 |
|
BDX
Becton Dickinson Co
|
203.40 | 57.96B | 21.84B | 1.68B | 2.67B | 5.8293 |
|
ALC
Alcon Inc
|
80.87 | 39.68B | 10.19B | 1.05B | 1.38B | 2.1044 |
|
MDLN
Medline Inc
|
46.31 | 37.32B | 27.43B | 1.27B | 1.01B | 1.5829 |
|
RMD
Resmed Inc
|
255.50 | 37.29B | 5.26B | 1.44B | 1.76B | 9.7713 |
Kestra Medical Technologies Ltd Stock (KMTS) Upgrades & Downgrades
| 日付 | アクション | アナリスト | 評価の変更 |
|---|---|---|---|
| 2025-11-18 | 開始されました | BTIG Research | Buy |
| 2025-03-31 | 開始されました | BofA Securities | Buy |
| 2025-03-31 | 開始されました | Goldman | Neutral |
| 2025-03-31 | 開始されました | Piper Sandler | Overweight |
| 2025-03-31 | 開始されました | Stifel | Buy |
| 2025-03-31 | 開始されました | Wells Fargo | Overweight |
| 2025-03-31 | 開始されました | Wolfe Research | Outperform |
すべてを表示
Kestra Medical Technologies Ltd (KMTS) 最新ニュース
Kestra Medical Technologies (KMTS) Stock Analysis: Exploring a Promising 16.84% Upside in the Healthcare Sector - directorstalkinterviews.com
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Average Recommendation of “Moderate Buy” by Brokerages - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) versus Envista (NYSE:NVST) Head to Head Analysis - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Shares Gap UpShould You Buy? - MarketBeat
Published on: 2026-01-21 23:54:20 - baoquankhu1.vn
Kestra Medical Technologies (NASDAQ:KMTS) Insider Brian Daniel Webster Sells 15,000 Shares - Defense World
Short Interest in Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Rises By 21.5% - Defense World
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Sees Large Growth in Short Interest - MarketBeat
Should value investors consider Kestra Medical Technologies Ltd.July 2025 Trade Ideas & Weekly High Return Forecasts - bollywoodhelpline.com
Institutions along with private equity firms who hold considerable shares inKestra Medical Technologies, Ltd. (NASDAQ:KMTS) come under pressure; lose 6.5% of holdings value - Yahoo Finance
Analysts Offer Insights on Healthcare Companies: Solventum Corporation (SOLV) and Praxis Precision Medicines (PRAX) - The Globe and Mail
KMTS, Biobeat Partner to Expand Diagnostic Insight in Cardiac Recovery - TradingView
Kestra Medical Technologies, Biobeat Technologies to Collaborate - Diagnostic and Interventional Cardiology
Kestra Medical partners with Biobeat to add blood pressure monitoring By Investing.com - Investing.com Nigeria
KMTS: Strong clinical data and innovation drive rapid growth and margin expansion in the WCD market - TradingView
Kestra Medical partners with Biobeat to add blood pressure monitoring - Investing.com
Kestra Medical Technologies Announces Strategic Collaboration with Biobeat Technologies to Expand Diagnostic Insight for Wearable Defibrillator Patients During Cardiac Recovery - GlobeNewswire
Market Rankings: Will Kestra Medical Technologies Ltd outperform its industry peersPortfolio Performance Summary & Fast Gain Swing Trade Alerts - baoquankhu1.vn
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 6% – What’s Next? - Defense World
Goldman Sachs Maintains Kestra Medical Technologies(KMTS.US) With Hold Rating, Raises Target Price to $27 - 富途牛牛
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6%Time to Sell? - MarketBeat
Is Kestra Medical Technologies Ltd. stock positioned for long term growthEarnings Risk Report & Weekly Hot Stock Watchlists - ulpravda.ru
Will Kestra Medical Technologies Ltd. stock return to pre crisis levelsJuly 2025 Highlights & Long-Term Capital Growth Strategies - Улправда
Kestra Medical Technologies (KMTS) Stock Analysis: Strong Revenue Growth and 19% Potential Upside - directorstalkinterviews.com
Kestra Medical Technologies (NASDAQ:KMTS) Stock Price Down 6.1% – Here’s Why - Defense World
Kestra Medical Technologies (NASDAQ:KMTS) Trading Down 6.1%Here's What Happened - MarketBeat
Traci Umberger Sells 10,500 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock - Defense World
Brian Daniel Webster Sells 15,000 Shares of Kestra Medical Technologies (NASDAQ:KMTS) Stock - Defense World
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of “Moderate Buy” by Brokerages - Defense World
Webster, Kestra medical CEO, sells $398k in shares By Investing.com - Investing.com Australia
Insider Selling: Kestra Medical Technologies (NASDAQ:KMTS) Insider Sells 10,500 Shares of Stock - MarketBeat
Kestra Medical Technologies Insider Sold Shares Worth $280,201, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies Insider Sold Shares Worth $398,847, According to a Recent SEC Filing - marketscreener.com
Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Given Consensus Recommendation of "Moderate Buy" by Brokerages - MarketBeat
Kestra Medical Technologies to Present at the 44th Annual J.P. Morgan Healthcare Conference - The Manila Times
Both Private Equity Firms Who Control a Good Portion of Kestra Medical Technologies, Ltd. (NASDAQ:KMTS) Along With Institutions Must Be Dismayed After Last Week's 3.1% Decrease - 富途牛牛
Biobeat Technologies Ltd. announced that it has received $50 million in funding from Ally Bridge Group, OrbiMed Advisors LLC, Elevage Medical Technologies, Kestra Medical Technologies, Ltd. and other investors - marketscreener.com
Kestra Medical Technologies Ltd (KMTS) is an excellent investment, but the stock is overvalued/undervalued right now - uspostnews.com
Can Kestra Medical Technologies Ltd. stock maintain operating margins2025 Volume Leaders & AI Driven Stock Reports - Улправда
Will Kestra Medical Technologies Ltd. stock benefit from AI adoptionJuly 2025 Weekly Recap & Risk Controlled Swing Alerts - Улправда
Kestra Medical Technologies sees Q2 revenue between $22.2M and $22.6M - MSN
Is Kestra Medical Technologies (KMTS) Overvalued After Its Recent Share Price Climb? - Sahm
Kestra Medical prices upsized $138M offering - MSN
Kestra Medical Technologies reports strong earnings growth - MSN
Kestra Medical Technologies (KMTS) Q2: Revenue Growth, Losses Deepen, Testing Bullish Scale Narratives - Sahm
Wells Fargo Maintains Kestra Medical Technologies (KMTS) Overweight Recommendation - Nasdaq
Kestra Medical Technologies’ revenue up 53% to USD 22.6M in Q2 FY26 - Medical Buyer
Kestra Medical Technologies, Ltd. $KMTS Position Increased by Eventide Asset Management LLC - MarketBeat
Kestra Medical Technologies Ltd (KMTS) 財務データ
Kestra Medical Technologies Ltd (KMTS) の財務データはありません。詳細については、他の銘柄を確認してください。
収益
当期純利益
現金流量
EPS
大文字化:
|
ボリューム (24 時間):